🇪🇺 TRASTUZUMAB EMTANSINE in European Union

TRASTUZUMAB EMTANSINE (TRASTUZUMAB EMTANSINE) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/002389
  • Local brand name: Kadcyla
  • Status: approved

TRASTUZUMAB EMTANSINE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is TRASTUZUMAB EMTANSINE approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for TRASTUZUMAB EMTANSINE in European Union?

Marketing authorisation holder not available in our data.